# Meditrina, Inc.

- Location (FDA's records): San Jose, CA
- FDA decisions: 5 (2019–2023): 5 510(k) clearances
- Product codes: HIH (5)
- 510(k) review time since 2016: median 113 days, against 91 for FDA's reviews in the same codes and years (2 of 4 faster)
- Predicates its devices cite: 8 (4 its own); citations of its devices by later devices: 4 (4 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Smith & Nephew, Inc.: 2 (https://510kreport.com/company/smith-nephew)
- W.O.M. World of Medicine GmbH: 1 (https://510kreport.com/company/wom-world-of-medicine)
- Gynecare, Inc.: 1 (https://510kreport.com/company/gynecare)

## Its most-cited devices
- K190372: Aveta System (2019), cited by 3
- K213171: Aveta System, Aveta Disposable Hysteroscope (Pearl/Opal/Coral), Aveta Disposable Cystoscope (Coral) (2022), cited by 1

## Recent decisions
- K223813: Aveta System 2.0 (Aug 21, 2023)
- K213171: Aveta System, Aveta Disposable Hysteroscope (Pearl/Opal/Coral), Aveta Disposable Cystoscope (Coral) (May 26, 2022)
- K192100: Aveta Disposable Hysteroscope (Dec 19, 2019)
- K191958: Aveta System (Oct 1, 2019)
- K190372: Aveta System (May 16, 2019)

Source page: https://510kreport.com/company/meditrina